Talk:Plerixafor
From Wikipedia, the free encyclopedia
 |
Plerixafor is within the scope of WikiProject Chemicals, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project. | ||
 |
This article is also supported by WikiProject Chemistry. | ||
|
Article Grading: The article has not been rated for quality and/or importance yet. Please rate the article and then leave comments here to explain the ratings and/or to identify the strengths and weaknesses of the article.. |
|||
 |
Plerixafor is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| Stub | This article has been rated as Stub-Class on the quality scale. |
|
|
|
[edit] Cancer inhibitor
Should I say "small molecule cancer therapy?" —Preceding unsigned comment added by 165.123.243.168 (talk) 02:13, 13 December 2007 (UTC)
[edit] Move
I propose this page be moved to plerixafor in accordance with WikiProject Pharmacology Naming conventions, as plerixafor is the recommended International Nonproprietary Name: [1].
If there is no objection, I will perform the move in 24 hours. Fvasconcellos 18:40, 24 March 2007 (UTC)
- I have no objection. --Arcadian 19:45, 24 March 2007 (UTC)
- Well, if the article creator doesn't object... :) I'll wait until tomorrow anyway, pro forma. Fvasconcellos 22:50, 24 March 2007 (UTC)
- Move done. Fvasconcellos 02:49, 26 March 2007 (UTC)
